News | April 26, 2023
Siegfried breaks ground on new R&D center for drug substances in Switzerland
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Bridging the gap between histopathology and molecular pathology
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Metronidazole is an antibiotic used on the skin to treat a certain skin disorder known as rosacea
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite
Apollo continues to invest in genomics technology and research for better patient care
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Subscribe To Our Newsletter & Stay Updated
